Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
AHCA/NCAL, 15 other groups pressure HHS to extend public health emergency
By
Lois A. Bowers
May 12, 2022
Sixteen national organizations were thinking of fall and the flu Tuesday when they asked HHS Secretary Xavier Becerra to extend the public health emergency related to COVID-19.
LeadingAge’s president and CEO has asked Congress to ensure access to COVID-19 tests, vaccines and treatments in letters supporting the White House’s request for COVID-19 supplemental funds.
OSHA accepting new comments on healthcare worker COVID-19 protection rule
By
Lois A. Bowers
Mar 23, 2022
The Occupational Safety and Health Administration is accepting additional comments as it establishes a final rule meant to protect long-term care workers and other healthcare providers from exposure to...
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
COVID-19 vaccinations are essentially at a standstill in U.S. nursing homes and assisted living communities due to federal officials’ call today for a pause on the use of the Johnson & Johnson vaccine.
Staff buy-in key to reducing ED visits with telemedicine, senior living study finds
By
Alicia Lasek
Feb 23, 2021
An attempt to reduce unnecessary emergency department visits with telemedicine triage failed when senior living healthcare providers were not on board. The findings contain lessons for for clinicians and...
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
CVS: Independent living residents will continue to wait for COVID-19 vaccination
By
Kimberly Bonvissuto
Jan 06, 2021
Independent living residents, even those who live in CCRCs, will have to continue to wait for COVID-19 vaccination, according to one of the retail giants administering the vaccines in long-term care.
College town coronavirus outbreak linked to rise in nursing home cases and deaths
By
Danielle Brown
Oct 23, 2020
Officials of a Wisconsin college town are sounding the alarm after a rise in coronavirus cases among students in September was followed by a devastating increase in cases and deaths among nursing home...